Sign Up
Ready to replace complexity with clarity?
Answer your real world compliance questions (limited time) and save thousands in legal fees and avoided fines.
Automate Compliance TodayUS states A to Z: marijuana, THCA, delta-8, delta-9, delta-10, HHC
State-by-state mapMost read countries: marijuana, CBD and hemp status
All countries on the globeSubstances: status in every state for each one
Compare all substancesFederal hemp redefinition: P.L. 119-103, div. B, sec. 2019
Nov 12, 2026
Applies only to cannabinoids the plant cannot naturally produce.
Dec 11, 2026
The total-THC test, the 0.4 mg per container cap and the exclusion of converted cannabinoids start.
Latest regulatory actions, updated daily
All regulatory actionsHeadlines and the first four sentences are free. Full write-ups, impact reasoning and the archive are for members.
Member · $99/mo
Every rule change, the day it is made.
The price will rise. Join now and $99 a month stays your rate for life.
Become a memberOr read free: every action opens 30 days after it is published. Sign in with email
By topic
Licensing and permitsPackaging and labelingLab testing and QARetail complianceAdvertising and marketingBanking and paymentsTaxesShipping and logisticsTravel and transportLitigationSOPsFor your role
Regulators and agenciesBrands and operatorsRetailers and smoke shopsCultivatorsProcessorsLawyers and complianceInvestorsConsumers and travelersThe Regulator Brief · newsletter
Every rule change that matters, every Monday.
Free: the Monday brief, and every action 30 days after it is published.
Members: the paid weekly, daily alerts and every write-up.
Read by regulators, operators, lawyers and founders.
Cannabis lawyers
Licensed by state. Listings are not endorsements.
By state
Software and services
Compared by fit, never ranked.
Categories
For companies and firms
Be the listing operators and regulators find.
Software and services
Verified, $49/mo: domain-verified badge, your website link, a quote.
Featured, from $399/mo: labeled Featured in your category, monthly release notes.
Lawyers and firms
Claimed, $75/yr: Claimed badge and your firm's website link.
Featured, $199/mo: labeled Featured on your profile.
Claim your companyClaim a lawyer listingPlacements, flat monthly fee
State and country page sponsorshipsExclusive slot on a legality page and its postsRegulator Brief sponsorshipPresenting sponsor or mid-issue banner, free editionMember brief sponsor slotThe paid weekly, read by members onlyFeatured directory placementLabeled Featured in a software categoryCategory sponsorshipOwn one directory category across the sitePaid guest postsLabeled Paid guest post, sponsored linksWrite and partner
Pitch a paid guest postRead guest postsBecome an affiliateSend a tip or correctionContact the teamWho reads it
Regulators at federal, state and county agencies, plus the operators, lawyers and founders they regulate.
Get the media kitSee open placementsSubstances
US states, map and A to ZCountriesFederal hemp 2026: Nov 12 and Dec 11Compound index, every stateTravelling with cannabis or hempMembers get the daily alert email and every full write-up the morning it is published. Every action is free to read 30 days later.
For your role
All news and analysisGuidesAnalysisFAQsTemplates and SOPsCourt filing recapsNews by state and countrySoftware and services: Verified $49/mo, Featured from $399/mo. Lawyers and firms: Claimed $75/yr, Featured $199/mo. Listings are not endorsements.
Regulatory journalism, not legal advice. How we report

Mexico COFEPRIS 2025 CBD imports will be dramatically impacted by two synchronized regulatory shifts: the June 11, 2025 COFEPRIS agreement for faster health product authorizations and a September 2025 suite of looming customs/tariff reforms now being debated. For CBD and hemp importers, this is a critical inflection point—especially for those seeking compliance and sustained business in Mexico’s evolving legal environment.
On June 11, 2025, the Mexican health regulator—COFEPRIS—published a landmark agreement designed to accelerate regulatory decisions and more closely align with international standards, including those of the Pan American Health Organization (PAHO) and recognized foreign regulatory agencies. The new process signals a marked departure from the historically slow, paper-heavy approach, emphasizing:
For CBD products, this creates more predictability in import licensing, provided applicants:
Despite digital progress, Mexico’s CBD permissions remain medical-only in practical terms. The regulatory risk for food, beauty, and over-the-counter wellness importers remains high. COFEPRIS visibly polices claims and product categories for everything perceived as novel or misaligned with established therapeutic applications. Expect:
Pro tip: Preemptively structure dossiers to reinforce “medical use only.” For all other categories, consult regularly with COFEPRIS and industry specialists, and monitor evolving standards via official COFEPRIS updates.
On September 9, 2025, the federal executive presented a major customs/tariff reform package, forming part of the broad 2026 Economic Package. This plan, covered here, aims to:
For CBD importers, this means even minor errors—improper HS coding, missing paperwork, unsupported claims, or misclassified formulations—could result in shipment seizures, stiff penalties, or even criminal investigations by Mexican authorities in 2026.
With COFEPRIS and SAT (customs authority) both moving to digital, applicant files must be:
Use “mutual recognition” principles:
With timelines collapsing under the new June 2025 agreement, importers need agile compliance teams able to:
Expect more robust enforcement as COFEPRIS’ modernization and customs digitalization converge:
Build now, not later. With both COFEPRIS and customs authorities tightening digital, documentation, and product integrity standards, importers should:
Mexico COFEPRIS 2025 CBD imports compliance is transforming from a fragmented, paper-based challenge into a digitally governed, highly professionalized process as 2025 transitions into 2026. The only way to seize market opportunity is to build for these new realities: robust, digital compliance management, pre-audited import files, and constant alignment with shifting customs requirements and medical-use guardrails.
Stay informed and ready—visit CannabisRegulations.ai for the latest developments and practical compliance support tailored to your business. The landscape is shifting—be first, be ready, and be compliant.